Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00207571 · ClinicalTrials.gov registry record · Phase 1

Partner Notification Intervention for STD Clinics.

A Phase 1 study of Contact Tracing, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
Phase 1
Development phase
150
Enrollment target
1
Study location

NCT00207571: Completed Phase 1 study of Contact Tracing, sponsored by Centers for Disease Control and Prevention.

NCT00207571 is a Phase 1 study of Contact Tracing that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 150 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (150% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00207571, a Phase 1 study of Contact Tracing, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
Phase 1
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

To help public health professionals (DIS) in interviews of patients infected with STD for the names of their sex partners, this project used a computer-based partner elicitation program before the actual DIS interview. The main outcome was the mean number of partners named by those who had the intervention versus those those who did not.

Conditions Studied

Interventions

  • BEHAVIORAL Computer

Study Locations (1)

Oregon

  • Oregon Research Institute - Eugene

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2001-04
Est. Completion 2005-10
Phase Phase 1

What the finished NCT00207571 record still lists

NCT00207571 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (150% higher).

The record links to 1 condition, with Contact Tracing appearing as the primary indexed condition, and to 1 intervention - of which Computer is the first listed.

NCT00207571 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT00207571 about?

NCT00207571 is a clinical study titled "Partner Notification Intervention for STD Clinics.". To help public health professionals (DIS) in interviews of patients infected with STD for the names of their sex partners, this project used a computer-based partner elicitation program before the actual DIS interview. The main outcome was the mean number of partners named by those who had the inter...

What is the current status of trial NCT00207571?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2001-04. Estimated completion is 2005-10.

What conditions does trial NCT00207571 study?

This clinical trial studies the following conditions: Contact Tracing.

What interventions are being tested in trial NCT00207571?

The interventions under investigation include: Computer (BEHAVIORAL).

Who is sponsoring clinical trial NCT00207571?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00207571 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT00207571's enrollment target sits among peer trials

150 363rd of 2000 higher than 1,620 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00207571, the US trial registry maintained by the National Library of Medicine. NCT00207571 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.